• Priority Review of Drug Submissions (Therapeutic Products)
• Guidance for Industry - Priority Review of Drug Submissions
• Policy Issues: Filing of Supplemental New Drug Submissions, Supplemental Abbreviated New Drug …
• Drug and Health Product Submissions Under Review (SUR): New drug submissions under …
• Drug and Health Product Submissions Under Review (SUR): New drug submissions completed